Diarrhoea in irradiated patients: A prospective multicentre observational study

Stefano Pergolizzi, Ernesto Maranzano, Verena De Angelis, Marco Lupattelli, Paolo Frata, Stefano Spagnesi, Maria Luisa Frisio, Giovanni Mandoliti, Pietro Delia, Giuseppe Malinverni, Fabio Trippa, Letizia Fabbietti, Salvatore Parisi, Pietro De Vecchi, Giuseppe Sansotta, Celestino Giorgetti, Tiziano Bergami, Roberto Orecchia, Maurizio Portaluri, Marco SignorAntonio Pontoriero, Anna Santacaterina, Davide Di Gennaro

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Aims: To determine the incidence of cancer treatment-induced diarrhoea in patients submitted to irradiation. Methods: Forty-five Italian radiation oncology departments took part in this prospective observational study and a total of 1020 patients were enrolled. The accrual lasted three consecutive weeks; evaluation was based on diary cards filled in daily by patients during radiotherapy and one week after cessation. Diary cards recorded both the onset and intensity of diarrhoea. Results: A total of 1004 patients were eligible for this analysis. 147/1004 (14.6%) patients had diarrhoea. The median minimum number of daily events was 1 (range 1-7) with a median maximum events of 3 (range 1-23). 82/147 patients (56.2%) had a drug prescription for diarrhoea. In the evaluation of the onset of diarrhoea, in multivariate analysis, we found the following factors to be statistically significant predictors of an increased likelihood of diarrhoea: primitive tumour site, therapeutic purpose and field size. Conclusions: Patients with abdominal-pelvic cancer, treated with curative purpose and using large field sizes are at high risk of cancer treatment-induced diarrhoea. Diarrhoea was also observed in patients treated at other sites. In this population group there is the need for more stringent monitoring during the delivery of radiation therapy.

Original languageEnglish
Pages (from-to)933-937
Number of pages5
JournalDigestive and Liver Disease
Volume45
Issue number11
DOIs
Publication statusPublished - Nov 2013

Fingerprint

Multicenter Studies
Observational Studies
Diarrhea
Radiotherapy
Pelvic Neoplasms
Drug Prescriptions
Neoplasms
Radiation Oncology
Population Groups
Therapeutics
Multivariate Analysis
Prospective Studies
Incidence

Keywords

  • Diarrhoea
  • Multicentre
  • Observational
  • Radiotherapy

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Pergolizzi, S., Maranzano, E., De Angelis, V., Lupattelli, M., Frata, P., Spagnesi, S., ... Di Gennaro, D. (2013). Diarrhoea in irradiated patients: A prospective multicentre observational study. Digestive and Liver Disease, 45(11), 933-937. https://doi.org/10.1016/j.dld.2013.04.012

Diarrhoea in irradiated patients : A prospective multicentre observational study. / Pergolizzi, Stefano; Maranzano, Ernesto; De Angelis, Verena; Lupattelli, Marco; Frata, Paolo; Spagnesi, Stefano; Frisio, Maria Luisa; Mandoliti, Giovanni; Delia, Pietro; Malinverni, Giuseppe; Trippa, Fabio; Fabbietti, Letizia; Parisi, Salvatore; De Vecchi, Pietro; Sansotta, Giuseppe; Giorgetti, Celestino; Bergami, Tiziano; Orecchia, Roberto; Portaluri, Maurizio; Signor, Marco; Pontoriero, Antonio; Santacaterina, Anna; Di Gennaro, Davide.

In: Digestive and Liver Disease, Vol. 45, No. 11, 11.2013, p. 933-937.

Research output: Contribution to journalArticle

Pergolizzi, S, Maranzano, E, De Angelis, V, Lupattelli, M, Frata, P, Spagnesi, S, Frisio, ML, Mandoliti, G, Delia, P, Malinverni, G, Trippa, F, Fabbietti, L, Parisi, S, De Vecchi, P, Sansotta, G, Giorgetti, C, Bergami, T, Orecchia, R, Portaluri, M, Signor, M, Pontoriero, A, Santacaterina, A & Di Gennaro, D 2013, 'Diarrhoea in irradiated patients: A prospective multicentre observational study', Digestive and Liver Disease, vol. 45, no. 11, pp. 933-937. https://doi.org/10.1016/j.dld.2013.04.012
Pergolizzi S, Maranzano E, De Angelis V, Lupattelli M, Frata P, Spagnesi S et al. Diarrhoea in irradiated patients: A prospective multicentre observational study. Digestive and Liver Disease. 2013 Nov;45(11):933-937. https://doi.org/10.1016/j.dld.2013.04.012
Pergolizzi, Stefano ; Maranzano, Ernesto ; De Angelis, Verena ; Lupattelli, Marco ; Frata, Paolo ; Spagnesi, Stefano ; Frisio, Maria Luisa ; Mandoliti, Giovanni ; Delia, Pietro ; Malinverni, Giuseppe ; Trippa, Fabio ; Fabbietti, Letizia ; Parisi, Salvatore ; De Vecchi, Pietro ; Sansotta, Giuseppe ; Giorgetti, Celestino ; Bergami, Tiziano ; Orecchia, Roberto ; Portaluri, Maurizio ; Signor, Marco ; Pontoriero, Antonio ; Santacaterina, Anna ; Di Gennaro, Davide. / Diarrhoea in irradiated patients : A prospective multicentre observational study. In: Digestive and Liver Disease. 2013 ; Vol. 45, No. 11. pp. 933-937.
@article{59f7a3aeeb484a36906daf81b917c10a,
title = "Diarrhoea in irradiated patients: A prospective multicentre observational study",
abstract = "Aims: To determine the incidence of cancer treatment-induced diarrhoea in patients submitted to irradiation. Methods: Forty-five Italian radiation oncology departments took part in this prospective observational study and a total of 1020 patients were enrolled. The accrual lasted three consecutive weeks; evaluation was based on diary cards filled in daily by patients during radiotherapy and one week after cessation. Diary cards recorded both the onset and intensity of diarrhoea. Results: A total of 1004 patients were eligible for this analysis. 147/1004 (14.6{\%}) patients had diarrhoea. The median minimum number of daily events was 1 (range 1-7) with a median maximum events of 3 (range 1-23). 82/147 patients (56.2{\%}) had a drug prescription for diarrhoea. In the evaluation of the onset of diarrhoea, in multivariate analysis, we found the following factors to be statistically significant predictors of an increased likelihood of diarrhoea: primitive tumour site, therapeutic purpose and field size. Conclusions: Patients with abdominal-pelvic cancer, treated with curative purpose and using large field sizes are at high risk of cancer treatment-induced diarrhoea. Diarrhoea was also observed in patients treated at other sites. In this population group there is the need for more stringent monitoring during the delivery of radiation therapy.",
keywords = "Diarrhoea, Multicentre, Observational, Radiotherapy",
author = "Stefano Pergolizzi and Ernesto Maranzano and {De Angelis}, Verena and Marco Lupattelli and Paolo Frata and Stefano Spagnesi and Frisio, {Maria Luisa} and Giovanni Mandoliti and Pietro Delia and Giuseppe Malinverni and Fabio Trippa and Letizia Fabbietti and Salvatore Parisi and {De Vecchi}, Pietro and Giuseppe Sansotta and Celestino Giorgetti and Tiziano Bergami and Roberto Orecchia and Maurizio Portaluri and Marco Signor and Antonio Pontoriero and Anna Santacaterina and {Di Gennaro}, Davide",
year = "2013",
month = "11",
doi = "10.1016/j.dld.2013.04.012",
language = "English",
volume = "45",
pages = "933--937",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier B.V.",
number = "11",

}

TY - JOUR

T1 - Diarrhoea in irradiated patients

T2 - A prospective multicentre observational study

AU - Pergolizzi, Stefano

AU - Maranzano, Ernesto

AU - De Angelis, Verena

AU - Lupattelli, Marco

AU - Frata, Paolo

AU - Spagnesi, Stefano

AU - Frisio, Maria Luisa

AU - Mandoliti, Giovanni

AU - Delia, Pietro

AU - Malinverni, Giuseppe

AU - Trippa, Fabio

AU - Fabbietti, Letizia

AU - Parisi, Salvatore

AU - De Vecchi, Pietro

AU - Sansotta, Giuseppe

AU - Giorgetti, Celestino

AU - Bergami, Tiziano

AU - Orecchia, Roberto

AU - Portaluri, Maurizio

AU - Signor, Marco

AU - Pontoriero, Antonio

AU - Santacaterina, Anna

AU - Di Gennaro, Davide

PY - 2013/11

Y1 - 2013/11

N2 - Aims: To determine the incidence of cancer treatment-induced diarrhoea in patients submitted to irradiation. Methods: Forty-five Italian radiation oncology departments took part in this prospective observational study and a total of 1020 patients were enrolled. The accrual lasted three consecutive weeks; evaluation was based on diary cards filled in daily by patients during radiotherapy and one week after cessation. Diary cards recorded both the onset and intensity of diarrhoea. Results: A total of 1004 patients were eligible for this analysis. 147/1004 (14.6%) patients had diarrhoea. The median minimum number of daily events was 1 (range 1-7) with a median maximum events of 3 (range 1-23). 82/147 patients (56.2%) had a drug prescription for diarrhoea. In the evaluation of the onset of diarrhoea, in multivariate analysis, we found the following factors to be statistically significant predictors of an increased likelihood of diarrhoea: primitive tumour site, therapeutic purpose and field size. Conclusions: Patients with abdominal-pelvic cancer, treated with curative purpose and using large field sizes are at high risk of cancer treatment-induced diarrhoea. Diarrhoea was also observed in patients treated at other sites. In this population group there is the need for more stringent monitoring during the delivery of radiation therapy.

AB - Aims: To determine the incidence of cancer treatment-induced diarrhoea in patients submitted to irradiation. Methods: Forty-five Italian radiation oncology departments took part in this prospective observational study and a total of 1020 patients were enrolled. The accrual lasted three consecutive weeks; evaluation was based on diary cards filled in daily by patients during radiotherapy and one week after cessation. Diary cards recorded both the onset and intensity of diarrhoea. Results: A total of 1004 patients were eligible for this analysis. 147/1004 (14.6%) patients had diarrhoea. The median minimum number of daily events was 1 (range 1-7) with a median maximum events of 3 (range 1-23). 82/147 patients (56.2%) had a drug prescription for diarrhoea. In the evaluation of the onset of diarrhoea, in multivariate analysis, we found the following factors to be statistically significant predictors of an increased likelihood of diarrhoea: primitive tumour site, therapeutic purpose and field size. Conclusions: Patients with abdominal-pelvic cancer, treated with curative purpose and using large field sizes are at high risk of cancer treatment-induced diarrhoea. Diarrhoea was also observed in patients treated at other sites. In this population group there is the need for more stringent monitoring during the delivery of radiation therapy.

KW - Diarrhoea

KW - Multicentre

KW - Observational

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84885435270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885435270&partnerID=8YFLogxK

U2 - 10.1016/j.dld.2013.04.012

DO - 10.1016/j.dld.2013.04.012

M3 - Article

C2 - 23790323

AN - SCOPUS:84885435270

VL - 45

SP - 933

EP - 937

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 11

ER -